Gastroenterology
Volume 128, Issue 7 , Pages 1812-1818, June 2005

A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine

  • Marc Lémann

      Affiliations

    • Hôpital Saint-Louis, Centre Hospitalier Universitaire Lariboisière-Saint-Louis, Paris, France
    • Corresponding Author InformationAddress requests for reprints to: Marc Lémann, MD, PhD, Service de Gastroentérologie, 1 Avenue Claude Vellefaux, 75010, Paris, France. fax: (33) 1-42-49-9168
    • ,
  • Jean-Yves Mary

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale ERM 0321, Paris, France
    • ,
  • Jean-Frédéric Colombel

      Affiliations

    • Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France
    • ,
  • Bernard Duclos

      Affiliations

    • Hôpital Hautepierre, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France
    • ,
  • Jean-Claude Soule

      Affiliations

    • Hôpital Bichat, Centre Hospitalier Universitaire Bichat-Beaujon, Paris, France
    • ,
  • Eric Lerebours

      Affiliations

    • Hôpital Charles Nicolle, Centre Hospitalier Universitaire de Rouen, Rouen, France
    • ,
  • Robert Modigliani

      Affiliations

    • Hôpital Saint-Louis, Centre Hospitalier Universitaire Lariboisière-Saint-Louis, Paris, France
    • ,
  • Yoram Bouhnik

      Affiliations

    • Hôpital Lariboisière, Centre Hospitalier Universitaire Lariboisière-Saint-Louis, Paris, France
    • ,
  • Groupe D’Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID)

Received 31 July 2004; accepted 2 March 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was initiated, designed, and conducted by GETAID. It was funded by grant supports from the Société Nationale Française de Gastroentérologie and by the Association François Aupetit. Drugs were provided by GlaxoSmithKline. All data analysis and writing were performed independently by GETAID, without the involvement of representatives of GlaxoSmithKline.

PII: S0016-5085(05)00448-8

doi:10.1053/j.gastro.2005.03.031

Refers to article:

  • Treatment of Crohn’s Disease: The “Long” of It

    Stephen B. Hanauer, Ronald A. Thisted
    Gastroenterology June 2005 (Vol. 128, Issue 7, Pages 2164-2166)

Gastroenterology
Volume 128, Issue 7 , Pages 1812-1818, June 2005

Article Tools

* Image Usage & Resolution